Skip to main content
2024 State-of-the Art Clinical Symposium Main banner
Final Program


Schedule at a Glance
Back

Lung Disease in Scleroderma

Sunday, April 14, 2024
9:10 AM – 9:40 AM Central Time

    Speaker(s)

  • Dinesh Khanna, MD, MSc

    University of Michigan
    Ann Arbor, MI, United States

    Disclosure(s): Chemomab: Advisor or Review Panel Member (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Zuro Bio: Consultant (Ongoing)

Disclosure(s):
Dinesh Khanna, MD, MSc: Chemomab: Advisor or Review Panel Member (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Zuro Bio: Consultant (Ongoing)
The session is will discuss the risk factors for ILD in systemic sclerosis (SSc) and present recent guidelines on screening and management of SSc-ILD.

Learning Objectives:

  • Discuss the risk factors for ILD in systemic sclerosis (SSc).
  • Discuss recent guidelines on screening and management of SSc-ILD.